February 8, 2021

Izzo NJ et al. Alzheimer’s Dement 2021;1–18.

Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification

Izzo NJ et al. Alzheimer'sDement 2021-image

 

Download publication